News

How can I find out about a trial that may be suitable for me?

As COVID-19 restrictions lift in England, we have joined 40 other cancer charities in an open letter to the public to raise awareness about the impact of ‘freedom day’ on people affected by cancer, and the steps people can take to protect those who are still clinically extremely vulnerable to COVID-19.

NICE has approved chlormethine gel for NHS use for adults with mycosis fungoides.

In an open letter to the public, and two letters addressed to the Prime Minister, we express our concern about the lifting of COVID-19 restrictions in England on Monday 19 July, and what this will mean for people considered clinically extremely vulnerable to COVID-19.

As restrictions are lifted and guidance on working from home will end, we consider what rights people with lymphoma have, the latest government guidance for England and include some questions you might ask your employer as you consider returning to work. 

This year, the British Society for Haematology held their annual scientific meeting online. Clinical experts presented some of the latest developments across all areas of lymphoma research.

Phase 3 of the COVID-19 vaccination programme will begin in the autumn with booster jabs for the most vulnerable people.

In most places, antibody tests to check your response to COVID vaccination are not routinely available on the NHS. Here, we list a few things to consider before deciding whether or not to pay for a private test.

A phase 1 trial of a new treatment called camidanlumab tesirine has found that this could be an effective option for people with lymphoma that has relapsed or is refractory after several previous courses of treatment.

Whether or not you choose to go out more, and how many people you choose to meet within the current rules, is a personal decision. To help you decide what you feel comfortable doing, we recap some of the main considerations and suggest things you can do to keep yourself safer.